The non-erythropoietic analogue cibinetide inhibits osteoclastogenesis in vitro and increases bone density in mice

• Zamzam Awida,
• Albert Kolomansky,
• Sahar Hiram-Bab,
• Nathalie Ben-Califa,
• Hussam Saad,
• Tamar Liron,
• Maria Ibrahim,
• Michael Brines,
• Yankel Gabet,
• Drorit Neumann

Affiliations

Zamzam Awida

Department of Cell and Developmental Biology, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel; Corresponding author.

Albert Kolomansky

Department of Cell and Developmental Biology, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel

Sahar Hiram-Bab

Department of Anatomy and Anthropology, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel

Nathalie Ben-Califa

Department of Cell and Developmental Biology, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel

Hussam Saad

Department of Cell and Developmental Biology, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel

Tamar Liron

Department of Anatomy and Anthropology, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel

Maria Ibrahim

Department of Cell and Developmental Biology, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel

Michael Brines

Araim Pharmaceuticals, Tarrytown, United States

Yankel Gabet

Department of Anatomy and Anthropology, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel

Drorit Neumann

Department of Cell and Developmental Biology, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel